These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20194300)

  • 1. Tonic chemoreflex activation contributes to increased sympathetic nerve activity in heart failure-related anemia.
    Franchitto N; Despas F; Labrunée M; Roncalli J; Boveda S; Galinier M; Senard JM; Pathak A
    Hypertension; 2010 Apr; 55(4):1012-7. PubMed ID: 20194300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excessive sympathetic activation in heart failure with chronic renal failure: role of chemoreflex activation.
    Despas F; Detis N; Dumonteil N; Labrunee M; Bellon B; Franchitto N; Galinier M; Senard JM; Pathak A
    J Hypertens; 2009 Sep; 27(9):1849-54. PubMed ID: 19542895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiorenal anemia syndrome in chronic heart failure contributes to increased sympathetic nerve activity.
    Franchitto N; Despas F; Labrunee M; Vaccaro A; Lambert E; Lambert G; Galinier M; Senard JM; Pathak A
    Int J Cardiol; 2013 Oct; 168(3):2352-7. PubMed ID: 23415171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral chemoreflex activation contributes to sympathetic baroreflex impairment in chronic heart failure.
    Despas F; Lambert E; Vaccaro A; Labrunee M; Franchitto N; Lebrin M; Galinier M; Senard JM; Lambert G; Esler M; Pathak A
    J Hypertens; 2012 Apr; 30(4):753-60. PubMed ID: 22241144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tonic chemoreflex activation contributes to the elevated muscle sympathetic nerve activity in patients with chronic renal failure.
    Hering D; Zdrojewski Z; Król E; Kara T; Kucharska W; Somers VK; Rutkowski B; Narkiewicz K
    J Hypertens; 2007 Jan; 25(1):157-61. PubMed ID: 17143187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal oxygen and muscle sympathetic nerve activity in heart failure.
    Andreas S; Bingeli C; Mohacsi P; Lüscher TF; Noll G
    Chest; 2003 Feb; 123(2):366-71. PubMed ID: 12576353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tonic chemoreflex activation does not contribute to elevated muscle sympathetic nerve activity in heart failure.
    van de Borne P; Oren R; Anderson EA; Mark AL; Somers VK
    Circulation; 1996 Sep; 94(6):1325-8. PubMed ID: 8822987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased sympathetic nerve activity in pulmonary artery hypertension.
    Velez-Roa S; Ciarka A; Najem B; Vachiery JL; Naeije R; van de Borne P
    Circulation; 2004 Sep; 110(10):1308-12. PubMed ID: 15337703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of peripheral chemoreceptors deactivation on sympathetic activity in heart transplant recipients.
    Ciarka A; Najem B; Cuylits N; Leeman M; Xhaet O; Narkiewicz K; Antoine M; Degaute JP; van de Borne P
    Hypertension; 2005 May; 45(5):894-900. PubMed ID: 15795365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea.
    Narkiewicz K; van de Borne PJ; Montano N; Dyken ME; Phillips BG; Somers VK
    Circulation; 1998 Mar; 97(10):943-5. PubMed ID: 9529260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sympathetic and reflex abnormalities in heart failure secondary to ischaemic or idiopathic dilated cardiomyopathy.
    Grassi G; Seravalle G; Bertinieri G; Turri C; Stella ML; Scopelliti F; Mancia G
    Clin Sci (Lond); 2001 Aug; 101(2):141-6. PubMed ID: 11473487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High dose ascorbic acid does not reverse central sympathetic overactivity in chronic heart failure.
    Gomes ME; El Messaoudi S; Lenders JW; Bellersen L; Verheugt FW; Smits P; Tack CJ
    J Clin Pharm Ther; 2011 Oct; 36(5):546-52. PubMed ID: 21916906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced sympathetic and ventilatory responses to central chemoreflex activation in heart failure.
    Narkiewicz K; Pesek CA; van de Borne PJ; Kato M; Somers VK
    Circulation; 1999 Jul; 100(3):262-7. PubMed ID: 10411850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Firing patterns of muscle sympathetic neurons during apnea in chronic heart failure patients and healthy controls.
    Zubin Maslov P; Shoemaker JK; Dujic Z
    Auton Neurosci; 2014 Feb; 180():66-9. PubMed ID: 24145048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced peripheral chemoreflex function in conscious rabbits with pacing-induced heart failure.
    Sun SY; Wang W; Zucker IH; Schultz HD
    J Appl Physiol (1985); 1999 Apr; 86(4):1264-72. PubMed ID: 10194212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tonic arterial chemoreceptor activity contributes to cardiac sympathetic activation in mild ovine heart failure.
    Xing DT; May CN; Booth LC; Ramchandra R
    Exp Physiol; 2014 Aug; 99(8):1031-41. PubMed ID: 24928955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tonic activity of carotid body chemoreceptors contributes to the increased sympathetic drive in essential hypertension.
    Siński M; Lewandowski J; Przybylski J; Bidiuk J; Abramczyk P; Ciarka A; Gaciong Z
    Hypertens Res; 2012 May; 35(5):487-91. PubMed ID: 22158114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short term effect of continuous positive airway pressure on muscle sympathetic nerve activity in patients with chronic heart failure.
    Heindl S; Dodt C; Krahwinkel M; Hasenfuss G; Andreas S
    Heart; 2001 Feb; 85(2):185-90. PubMed ID: 11156670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hypertension and obesity on the sympathetic activation of heart failure patients.
    Grassi G; Seravalle G; Quarti-Trevano F; Dell'Oro R; Bolla G; Mancia G
    Hypertension; 2003 Nov; 42(5):873-7. PubMed ID: 14568999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
    Palazzuoli A; Silverberg D; Iovine F; Capobianco S; Giannotti G; Calabrò A; Campagna SM; Nuti R
    Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.